XML 79 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Cash flows from operating activities:      
Net (loss) income $ (26,145) $ 92,731 $ 76,928
Deduct: Income (loss) from discontinued operations 20,155 (21) (672)
(Loss) income from continuing operations (46,300) 92,752 77,600
Adjustments to reconcile net income to net cash provided by operating activities:      
Deferred income taxes (3,257) (478) 24,375
Resolution of tax contingencies (4,405) (3,750)  
Non-cash interest expense   1,571 4,399
Depreciation and amortization 28,036 29,389 35,612
Intangible asset impairments 24,226    
Allowances against accounts receivable 24,439 (5,985) 2,101
Share-based compensation expense 9,830 14,074 13,737
Tax deficiency on exercises of stock options   (1,039)  
Other, net 1,298 1,093 614
Changes in assets and liabilities:      
(Increase) decrease in accounts receivable (39,588) 65,117 (74,451)
(Increase) decrease in inventories (12,191) 8,149 (36,404)
(Increase) decrease in prepaid expenses and other assets (1,454) (7,127) 5,313
Increase in accounts payable, accrued expenses and other liabilities 39,200 8,144 6,644
Increase (decrease) in payables due to distribution agreement partners 43,264 (33,242) (32,899)
Decrease (increase) in income taxes receivable/payable 1,880 (4,359) 26,707
Net cash provided by operating activities 64,978 164,309 53,348
Cash flows from investing activities:      
Capital expenditures (11,600) (10,685) (8,519)
Purchases of intangibles (34,450) (42,200) (1,000)
Business acquisitions (412,753)   (55,300)
Purchases of available for sale debt securities (26,026) (33,202) (10,000)
Proceeds from maturity and sale of available for sale marketable debt securities 26,973 44,053 65,366
Net cash used in investing activities (457,856) (42,034) (9,453)
Cash flows from financing activities:      
Borrowings under credit facility 350,000    
Proceeds from issuances of common stock upon exercise of stock options 10,350 24,794 718
Proceeds from the issuance of common stock under the Employee Stock Purchase Program 333 354 238
Excess tax benefits on share-based compensation   3,092 181
Purchase of treasury stock (8,004) (4,829) (2,187)
Reductions in principal due to maturity and repurchases of senior subordinated convertible notes   (47,746) (91,806)
Principal payments under long-term debt (4,375)    
Debt issuance costs (7,451) (934)  
Cash settlement of share-based compensation (4,133)    
Net cash provided by (used in) financing activities 336,720 (25,269) (92,856)
Net (decrease) increase in cash and cash equivalents (56,158) 97,006 (48,961)
Cash and cash equivalents at beginning of period 218,674 121,668 170,629
Cash and cash equivalents at end of period 162,516 218,674 121,668
Cash (received) paid during the period for:      
Income taxes, net (260) 48,517 (2,003)
Interest paid 1,361 1,372 3,800
Non-cash transactions:      
Capital expenditures incurred but not yet paid $ 764 $ 775 $ 620